JP2024503108A5 - - Google Patents

Info

Publication number
JP2024503108A5
JP2024503108A5 JP2023543115A JP2023543115A JP2024503108A5 JP 2024503108 A5 JP2024503108 A5 JP 2024503108A5 JP 2023543115 A JP2023543115 A JP 2023543115A JP 2023543115 A JP2023543115 A JP 2023543115A JP 2024503108 A5 JP2024503108 A5 JP 2024503108A5
Authority
JP
Japan
Prior art keywords
sequence
promoter
nucleic acid
extended
alphavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023543115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503108A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/013004 external-priority patent/WO2022159511A2/en
Publication of JP2024503108A publication Critical patent/JP2024503108A/ja
Publication of JP2024503108A5 publication Critical patent/JP2024503108A5/ja
Pending legal-status Critical Current

Links

JP2023543115A 2021-01-19 2022-01-19 改良型アルファウイルスベクター Pending JP2024503108A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163139297P 2021-01-19 2021-01-19
US63/139,297 2021-01-19
PCT/US2022/013004 WO2022159511A2 (en) 2021-01-19 2022-01-19 Modified alphavirus vectors

Publications (2)

Publication Number Publication Date
JP2024503108A JP2024503108A (ja) 2024-01-24
JP2024503108A5 true JP2024503108A5 (cg-RX-API-DMAC7.html) 2025-01-27

Family

ID=82549040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023543115A Pending JP2024503108A (ja) 2021-01-19 2022-01-19 改良型アルファウイルスベクター

Country Status (9)

Country Link
US (1) US20240167057A1 (cg-RX-API-DMAC7.html)
EP (1) EP4281110A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024503108A (cg-RX-API-DMAC7.html)
KR (1) KR20230134138A (cg-RX-API-DMAC7.html)
CN (1) CN117279660A (cg-RX-API-DMAC7.html)
AU (1) AU2022210420A1 (cg-RX-API-DMAC7.html)
CA (1) CA3205216A1 (cg-RX-API-DMAC7.html)
IL (1) IL304311A (cg-RX-API-DMAC7.html)
WO (1) WO2022159511A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022268916A2 (en) * 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine
EP4522754A1 (en) * 2022-05-12 2025-03-19 Sunvax MRNA Therapeutics Inc. Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator
WO2024026553A1 (en) * 2022-08-03 2024-02-08 Centre Hospitalier De L'université De Montréal Novel antigenic epitope against sars-cov-2 and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007994A2 (en) * 1993-09-15 1995-03-23 Viagene, Inc. Recombinant alphavirus vectors
US20090104226A1 (en) * 2004-05-21 2009-04-23 Novartis Vaccines And Diagnostics Inc. Alphavirus Vectors for Respiratory Pathogen Vaccines
BR112014008694A2 (pt) * 2011-10-11 2017-06-20 Novartis Ag moléculas de ácido nucleico policistrônico recombinante
KR102945203B1 (ko) * 2017-05-08 2026-03-31 시애틀 프로젝트 코포레이션 알파바이러스 신생항원 벡터

Similar Documents

Publication Publication Date Title
JP2021525076A5 (cg-RX-API-DMAC7.html)
JP2023526495A5 (cg-RX-API-DMAC7.html)
US20240209379A1 (en) Compositions and methods for enhancing gene expression
JP2023521662A5 (cg-RX-API-DMAC7.html)
US20230270841A1 (en) Coronavirus vaccine
JP2022512912A5 (cg-RX-API-DMAC7.html)
AU699384B2 (en) Alphavirus cDNA vectors
US20240123049A1 (en) Cis-replicon construct
JP2023541108A5 (cg-RX-API-DMAC7.html)
JP2022534282A5 (cg-RX-API-DMAC7.html)
WO2008119827A1 (en) Transreplicase constructs
JP2021524247A5 (cg-RX-API-DMAC7.html)
US20170314043A1 (en) Recombinant arterivirus replicon systems and uses thereof
RU2015103891A (ru) Комплексы белков цитомегаловируса
JP2023509966A5 (cg-RX-API-DMAC7.html)
JP2002537844A (ja) ヘルパーウイルス無しで安定な組換えインフルエンザウイルス
JP2023523413A5 (cg-RX-API-DMAC7.html)
JP2022539417A5 (cg-RX-API-DMAC7.html)
EP2331557B1 (en) Alphavirus packaging cell lines
WO2024152996A1 (zh) 自复制信使核糖核酸疫苗
EP3865180A1 (en) Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses
JP2024542126A5 (cg-RX-API-DMAC7.html)
Ooi et al. The full-length clone of cucumber green mottle mosaic virus and its application as an expression system for Hepatitis B surface antigen
CN113430178B (zh) 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用
WO2025157249A1 (zh) 一种自复制rna及其用途